Jacek Wachowiak Selected Research

Jacek Wachowiak Research Topics

Disease

21	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2002
18	Leukemia 07/2020 - 01/2002
14	Neoplasms (Cancer) 10/2021 - 01/2002
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2021 - 01/2003
6	Lymphoma (Lymphomas) 01/2016 - 01/2003
5	Infections 01/2022 - 01/2016
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 06/2018
5	Aplastic Anemia (Anemia, Hypoplastic) 10/2020 - 01/2005
3	Residual Neoplasm 11/2008 - 01/2006
2	Down Syndrome (Down's Syndrome) 09/2021 - 05/2017
2	Neuroblastoma 01/2021 - 07/2006
2	Communicable Diseases (Infectious Diseases) 06/2020 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2020 - 09/2019
2	Cognitive Dysfunction 01/2020 - 02/2017
2	Mycoses (Diseases, Fungus) 01/2020 - 09/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 01/2005
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2012 - 01/2006
2	Hodgkin Disease (Hodgkin's Disease) 01/2010 - 01/2006
2	Neutropenia 07/2007 - 07/2006
1	Disease Progression 01/2022
1	COVID-19 10/2021
1	Hemorrhagic Cystitis 05/2021
1	Hypothyroidism 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Vomiting 01/2020
1	Mucositis 01/2020
1	Hematologic Diseases (Blood Diseases) 01/2020
1	Iron Overload 01/2020
1	Pancreatitis 01/2019
1	Invasive Fungal Infections 10/2016
1	Chronic Granulomatous Disease 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2015
1	Myeloid Sarcoma (Chloroma) 06/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2013
1	Pain (Aches) 03/2012
1	Body Weight (Weight, Body) 02/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2010
1	Leukocytosis (Pleocytosis) 01/2010
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 07/2009

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 01/2002
4	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 05/2007
4	treosulfanIBA 01/2016 - 05/2007
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 07/2006
3	Methotrexate (Mexate)FDA LinkGeneric 10/2018 - 04/2012
3	Proteins (Proteins, Gene)FDA Link 11/2011 - 07/2006
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2008 - 01/2006
3	Immunoglobulins (Immunoglobulin)IBA 11/2008 - 01/2006
2	SteroidsIBA 10/2021 - 01/2019
2	Busulfan (Busulfex)FDA Link 05/2021 - 01/2016
2	LigandsIBA 05/2015 - 10/2014
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2008 - 07/2006
2	Prednisolone (Predate)FDA LinkGeneric 10/2008 - 07/2006
2	fludarabineIBA 05/2008 - 05/2007
2	DNA (Deoxyribonucleic Acid)IBA 07/2006 - 01/2006
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2003 - 01/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2021
1	Oxygen (Dioxygen)IBA 10/2021
1	Heparin (Liquaemin)FDA LinkGeneric 10/2021
1	remdesivirIBA 10/2021
1	Melphalan (Alkeran)FDA LinkGeneric 05/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2021
1	Biological ProductsIBA 07/2020
1	Hormones (Hormone)IBA 12/2019
1	Asparaginase (Elspar)FDA Link 01/2019
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 10/2018
1	EnzymesIBA 10/2018
1	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2017
1	Micafungin (FK463)FDA Link 10/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 06/2015
1	KIR ReceptorsIBA 10/2014
1	Rituximab (Mabthera)FDA Link 03/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2012
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2012
1	IronIBA 03/2012
1	Thymidylate SynthaseIBA 11/2011
1	Antineoplastic Agents (Antineoplastics)IBA 02/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 08/2010
1	Interleukin-2 (IL2)IBA 08/2010
1	AntigensIBA 07/2009

Therapy/Procedure

20	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2005
18	Therapeutics 10/2021 - 01/2002
13	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
8	Radiotherapy 10/2018 - 03/2004
7	Transplantation 01/2022 - 01/2004
6	Stem Cell Transplantation 01/2022 - 01/2004
4	Cell Transplantation 01/2022 - 09/2019
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020 - 07/2006
2	Aftercare (After-Treatment) 06/2015 - 10/2008
1	Donor Selection 01/2021
1	Parenteral Nutrition 01/2020
1	PVDA protocol 02/2013
1	Central Venous Catheters 03/2012
1	Length of Stay 03/2012
1	New York protocol 01/2010